Name: MD Income Statement - Pediatrix Medical Group. Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

MD - Pediatrix Medical Group. Inc.

USD | NYSE | Healthcare

MD Income Statement - Pediatrix Medical Group. Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	476.2	493.8	492.9	468.8	458.4	502.4	511.2	504.3	495.1	496.4	506.6	500.6	491.0	513.8	489.9	486.0

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	1,931.7	1,913.8	2,012.9	1,994.6	1,972.0	1,911.2	1,734.0	1,779.8	1,723.1	3,253.4	3,183.2	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income
Operating Income	218.4	208.8	(68.7)	7.3	172.7	202.9	98.1	171.8	248.4	454.9	571.7	557.9	513.0	452.1
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax & Net
Income Tax Expense	53.0	51.0	(2.3)	12.0	18.8	27.2	16.7	16.6	44.7	80.2	189.2	204.0	191.4	167.9	147.3
Per Share
EPS Basic	2.15	1.97	(1.19)	(0.73)	0.79	1.54	(9.55)	(17.94)	2.95	3.47	3.52	3.61	3.22	2.83	2.47	2.28
Supplementary Data
EBITDA	241.0	230.6	(36.5)	43.5	208.3	235.1	126.6	197.7	272.7	533.7	661.0	622.1	559.0	492.1	420.3	380.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	60.3	65.7	60.8	55.7	58.6	63.6	58.1	56.6	60.2	53.1	57.4	58.0	59.1	51.1	57.9	61.2	61.3
Depreciation & Amortization	6.1	5.6	5.6	5.3	5.3	6.9	6.3	8.8	10.3	9.1	9.2	8.9	9.0	9.1	9.0	8.8
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	434.5	445.0	424.8	409.0	426.3	463.1	477.3	662.0	479.2	607.9	466.3	452.1	461.0	477.8	442.5	435.9

Operating Income
Operating Income	41.7	48.8	68.1	59.9	32.1	39.3	33.8	(157.7)	15.9	(111.5)	40.3	48.5	30.0	36.0	47.4	50.2	39.1	68.0	58.8	50.0	26.1	32.3	20.5	34.6	10.8	(14.7)	48.6	59.4	78.5	(77.9)	104.2	122.4	99.7	100.5	126.4	121.9	106.0	142.8	156.9	147.8

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	8.3	8.7	8.9	9.1	9.2	9.7	10.1	10.3	10.6	10.1	10.4	11.2	10.4	10.0	9.5	8.4	11.8	16.6
Income From Equity Investments	0.7	0.8	1.9	0.5	0.4	0.9	0.4	0.5	0.5	0.5	0.7	0.5	0.4	0.4	0.4	0.4
Other Non-Operating Income	(2.8)	(3.2)	19.7	(4.9)	(4.0)	(6.0)	(8.6)	(10.0)	(8.1)	(27.4)	(9.4)	(9.6)	(9.3)	(8.2)	(8.5)	(7.1)	(67.5)
Pre-Tax Income	38.8	45.6	87.8	55.0	28.1	33.3	25.2	(167.7)	7.8	(138.9)	30.8	38.9	20.7	27.8	38.9	43.0	(28.3)

Tax & Net
Income Tax Expense	9.3	11.9	16.1	15.7	7.4	2.8	5.8	(14.7)	3.8	(14.6)	9.4	10.7	6.5	3.8	10.1	12.3	(7.4)	13.2	11.6	7.4	(5.0)	5.9	6.7	3.1	1.1	(11.2)	7.4	11.5	9.0	(30.1)	23.6	28.5	22.7	(37.6)	42.1	40.7	35.0	49.9	44.3	51.6
Net Income From Continuing Ops	29.6	33.7	71.7	39.3	20.7	30.5	19.4	(153.0)	4.0	(124.3)	21.4	28.3	14.2	24.0	28.8	30.7	(20.9)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	0.0	0.0	0.0	0.0	5.7	1.9	(3.6)	(0.2)
Net Income	29.6	33.7	71.7	39.3	20.7	30.5	19.4	(153.0)	4.0	(124.3)	21.4	28.3	14.2	29.7	30.7	27.1	(21.2)
Net Income Attributable To Parent	29.6	33.7	71.7	39.3	20.7	30.5	19.4	(153.0)	4.0	(124.3)	21.4	28.3	14.2	29.7	30.7	27.1
Less: Minority Interest	-	-	-	-	-	-	-	-	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	(0.0)	(0.0)
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	29.6	33.7	71.7	39.3	20.7	30.5	19.4	(153.0)	4.0	(124.3)	21.4	28.3	14.2	29.7	30.7

Per Share
EPS Basic	0.37	-	0.85	0.46	0.25	-	0.23	(1.84)	0.05	-	0.26	0.34	0.17	-	0.37	0.32	(0.25)	-	0.36	0.41	0.21	-	(0.49)	(8.06)	(0.22)	-	(15.23)	(0.10)	(2.82)	-	0.72	0.85	0.68	-	0.71	0.69	0.59	-	1.04	0.89
EPS Diluted	0.36	-	0.84	0.46	0.24	-	0.23	(1.84)	0.05	-	0.26	0.34	0.17	-	0.37	0.32	(0.25)	-
Shares Basic	80.9	-	84.6	84.8	84.4	-	83.9	83.3	82.9	-	82.5	82.4	81.9	-	82.1	85.1	85.4	-
Shares Diluted	83.1	-	85.6	85.5	85.4	-	84.5	83.3	83.3	-	83.0	82.7	82.3	-	82.8	85.6	85.4	-

Supplementary Data
EBITDA	47.8	54.4	73.6	65.2	37.4	46.2	40.1	(148.9)	26.2	(102.4)	49.5	57.4	39.0	45.2	56.3	58.9	47.9	75.9	66.9	58.1	34.1	40.0	27.7	41.3	17.6	(28.9)	55.0	73.2	98.5	(115.9)	126.4	142.7	119.6	102.9	151.5	147.6	131.7	168.0	181.1	168.0
EBIT	41.7	48.8	68.1	59.9	32.1	39.3	33.8	(157.7)	15.9	(111.5)	40.3	48.5	30.0	36.0	47.4	50.2	39.1	68.0	58.8